292 related articles for article (PubMed ID: 27992229)
1. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.
Leuthold P; Schaeffeler E; Winter S; Büttner F; Hofmann U; Mürdter TE; Rausch S; Sonntag D; Wahrheit J; Fend F; Hennenlotter J; Bedke J; Schwab M; Haag M
J Proteome Res; 2017 Feb; 16(2):933-944. PubMed ID: 27992229
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of narrow-bore and capillary liquid-chromatography for non-targeted metabolomics profiling by HILIC-QTOF-MS.
Neef SK; Hofmann U; Mürdter TE; Schwab M; Haag M
Talanta; 2023 Aug; 260():124578. PubMed ID: 37119797
[TBL] [Abstract][Full Text] [Related]
3. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS.
Neef SK; Winter S; Hofmann U; Mürdter TE; Schaeffeler E; Horn H; Buck A; Walch A; Hennenlotter J; Ott G; Fend F; Bedke J; Schwab M; Haag M
Anal Chim Acta; 2020 Oct; 1134():125-135. PubMed ID: 33059858
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Extraction of RNA and Metabolites from Single Kidney Tissue Specimens for Combined Transcriptomic and Metabolomic Profiling.
Leuthold P; Schwab M; Hofmann U; Winter S; Rausch S; Pollak MN; Hennenlotter J; Bedke J; Schaeffeler E; Haag M
J Proteome Res; 2018 Sep; 17(9):3039-3049. PubMed ID: 30091608
[TBL] [Abstract][Full Text] [Related]
5. Extending metabolome coverage for untargeted metabolite profiling of adherent cultured hepatic cells.
García-Cañaveras JC; López S; Castell JV; Donato MT; Lahoz A
Anal Bioanal Chem; 2016 Feb; 408(4):1217-30. PubMed ID: 26769129
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fully wettable RPLC stationary phases for LC-MS-based cellular metabolomics.
Si-Hung L; Causon TJ; Hann S
Electrophoresis; 2017 Sep; 38(18):2287-2295. PubMed ID: 28691762
[TBL] [Abstract][Full Text] [Related]
8. LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes.
Jing L; Guigonis JM; Borchiellini D; Durand M; Pourcher T; Ambrosetti D
Sci Rep; 2019 Oct; 9(1):15635. PubMed ID: 31666664
[TBL] [Abstract][Full Text] [Related]
9. Cross platform solutions to improve the zebrafish polar metabolome coverage using LC-QTOF MS: Optimization of separation mechanisms, solvent additives, and resuspension solvents.
Xu M; Legradi J; Leonards P
Talanta; 2021 Nov; 234():122688. PubMed ID: 34364485
[TBL] [Abstract][Full Text] [Related]
10. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
[TBL] [Abstract][Full Text] [Related]
11. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
12. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
13. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry.
Wang S; Zhou L; Wang Z; Shi X; Xu G
Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724
[TBL] [Abstract][Full Text] [Related]
15. Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
Huan T; Li L
Anal Chem; 2015 Jan; 87(2):1306-13. PubMed ID: 25496403
[TBL] [Abstract][Full Text] [Related]
16. MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues.
Jirásko R; Holčapek M; Khalikova M; Vrána D; Študent V; Prouzová Z; Melichar B
J Am Soc Mass Spectrom; 2017 Aug; 28(8):1562-1574. PubMed ID: 28361385
[TBL] [Abstract][Full Text] [Related]
17. A review of nanoscale LC-ESI for metabolomics and its potential to enhance the metabolome coverage.
Chetwynd AJ; David A
Talanta; 2018 May; 182():380-390. PubMed ID: 29501168
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
[TBL] [Abstract][Full Text] [Related]
19. Development, characterization and comparisons of targeted and non-targeted metabolomics methods.
Ribbenstedt A; Ziarrusta H; Benskin JP
PLoS One; 2018; 13(11):e0207082. PubMed ID: 30439966
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
